Navigation Links
Access Hybritech PSA Test

ProductsAccess Hybritech PSA Test
Company Beckman Coulter, Inc.
Item Access Hybritech PSA Test
Features 
  • Original Hybritech PSA monoclonal antibody pair now on Access!
  • Equimolar PSA measurement
  • Time to first result: 20 minutes
  • Curve stability: 28 days
  • Analytical sensitivity: <0.008 ng/mL
  • Measurement range: to 150 ng/mL
  • Precision: < 5% CV across assay range
Description A blood test, called the Prostate Specific Antigen (total PSA) test, has been used to help doctors decide how to manage patients with prostate cancer. Of the different PSA blood tests available, the Hybritech PSA test, was the first approved for the detection of prostate cancer when used in combination with digital rectal examination (DRE) in men aged 50 years or older.

Depending on the results of your DRE and total PSA test, your physician may decide to order an additional blood test, called free PSA. This test is used to help the physician interpret the results when the total PSA test, combined with a non-suspicious DRE, are ambiguous.

Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Access Immunoassay System
2. Access 2 Immunoassay System
3. Access Dilation Port
4. PINNACLE Introducer Sheath Designed for Vascular Access
5. FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating
6. CHECK-FLO Performer Introducer Sets For Radial Artery Access
7. CHECK-FLO Performer Introducer Sets Micropuncture Access
8. XPOSE 3 Access Device
9. XTD Hemodialysis Access Graft Thrombectomy Catheter
10. BD Visitrec Vitrectomy Unit and Accessories
11. EBI Access Pelvic Fixator
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
... Prostatic Stent may become a practice-changing technology ... the treatment of lower urinary tract symptoms ... Acute retention , Men unfit for surgery ... invasive therapy - TUMT, TUNA, Brachytherapy, Cryotherapy ...
Silver Foley Catheter 2-way...
Silver Foley Catheter 3-way...
Medicine Products:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: